the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
February 4, 2016 – This article is relied from FDA’s press release section and only very sightly edited. In response to the rampant opioid abuse epidemic in the United States (and very likely in other parts of the world too), Dr. …
July 6. 2015 – The American Food and Drug Administration (FDA) is once more investigating the safety of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including …
March 21, 2015 – The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recently recommended restrictions on the use of codeine-containing medicines for cough and cold in children because of the risk of serious side effects with these medicines, including the risk of breathing …
September 27, 2014 – A while ago (August 2012), the American Food and Drug Administration (FDA) was assessing and reporting on the (possibly fatal) risks associated with the use of codeine containing medicines in children who are phenotypically members of the …